Figure 3.
Stable in vivo selection of MGMT-transduced cells in a canine model suggests stem cell selection. Gene marking in granulocytes after in vivo selection of MGMT-transduced cells using O6BG and ascending doses of BCNU in a representative animal. Note that gene marking is maintained at levels higher than 87% with a follow-up of more than 9 months after the last drug administration.
